Acanthosis Nigricans: Variant Responds to Targeted Therapy

Early identification of the EGFR L858R variant in syndromic acanthosis enables effective treatment of skin and pulmonary manifestations, according to a case series. Medscape Medical News

Read the full article on medscape.com